Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by CERo Therapeutics Holdings, Inc. CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity November 11, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Provides Corporate Update October 21, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer October 02, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236 September 25, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024 July 08, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236 June 13, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236 June 06, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Provides Corporate Update for Shareholders May 15, 2024 From CERo Therapeutics Holdings, Inc. Via GlobeNewswire Tickers CERO CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients March 07, 2024 From CERo Therapeutics Holdings, Inc. Via Business Wire Tickers CERO Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
